Our Purpose

OptiNose’s innovative approach is designed to enable drug delivery deep in the nasal cavity, leveraging the mucosal surfaces as a potent target for the treatment of both local and systemic diseases. Known as Bi-Directional™ Breath Powered® Exhalation Delivery System, the OptiNose platform can potentially offer an alternative to conventional treatments. LEARN MORE »

Optinose Product Image

See how it works



OptiNose’s candidates include OPN-375 and AVP-825 being developed for Nasal Polyposis and Acute Migraine, respectively. We have also identified more than ten pipeline candidates that we believe hold outstanding potential to help patients using our Bi-Directional Breath Powered Exhalation Delivery System. VIEW CANDIDATES »

News & Media Coverage

View All News » View All Media Coverage »